Summary of harms of special interest and post hoc exploratory harm analysesa | Serious harms | New onset diseasesd | General harmse | ||||||
---|---|---|---|---|---|---|---|---|---|
HPV vaccine (N = 47,075) | Comparator (N = 48,595) | Risk ratiof[95% CI] | HPV vaccine (N = 47,075) | Comparator (N = 48,595) | Risk ratiof [95% CI] | HPV vaccine (N = 47,075) | Comparator (N = 48,595) | Risk ratiof [95% CI] | |
Harms of special interest (MedDRA-preferred terms, n = participants) | |||||||||
Anaphylaxis | 2 | 4 | 0.59 [0.13, 2.82] | 11 | 8 | 1.18 [0.48, 2.91] | 0 | 0 | Not applicable |
Chronic fatigue syndrome (CFS) | 0 | 0 | Not applicable | 0 | 0 | Not applicable | 0 | 0 | Not applicable |
Chronic regional pain syndrome (CRPS) | 0 | 0 | Not applicable | 0 | 0 | Not applicable | 0 | 0 | Not applicable |
Guillain-Barré syndrome (GBS) | 0 | 0 | Not applicable | 0 | 0 | Not applicable | 0 | 0 | Not applicable |
Postural orthostatic tachycardia syndrome (POTS) | 0 | 0 | Not applicable | 0 | 0 | Not applicable | 0 | 0 | Not applicable |
Premature ovarian failure (POF) | 0 | 0 | Not applicable | 1 | 0 | 3.00 [0.12, 73.48] | 0 | 0 | Not applicable |
Syncope | 4 | 3 | 0.94 [0.23, 3.81] | 62 | 60 | 1.03 [0.58, 1.84] | 7 | 7 | 0.77 [0.25, 2.34] |
Post hoc exploratory analyses of VigiBase® harm clustersb | |||||||||
Expected systemic reactions | 25 | 11 | 1.96 [0.96, 3.98] | 1465 | 1358 | 1.03 [0.93, 1.14] | 10,926 | 9948 | Not applicableg |
Allergic/hypersensitivity reactions | 2 | 2 | 0.96 [0.14, 6.52] | 284 | 279 | 1.05 [0.82, 1.35] | 1912 | 1469 | 1.30 [1.18, 1.45] |
Vasovagal reactions | 9 | 5 | 1.31 [0.50, 3.46] | 232 | 212 | 1.06 [0.78, 1.44] | 173 | 123 | 1.20 [0.93, 1.55] |
Post hoc exploratory analyses of CRPS and POTSc | |||||||||
Harms judged as ‘definitely associated’ with CRPS | 95 | 57 | 1.54 [1.11, 2.14] | 5079 | 4790 | 1.04 [0.98, 1.10] | 27,899 | 23,223 | Not applicableg |
Harms judged as ‘definitely associated’ with POTS | 56 | 26 | 1.92 [1.21, 3.07] | 3675 | 3352 | 1.08 [1.01, 1.15] | 18,207 | 16,288 | Not applicableg |